The Evofem Biosciences 2023 Annual Meeting of Stockholders was held September 14, 2023. The proxy statement is attached below (PDF) and linked here. Of the Company’s 8,560,209 eligible votes as of August 7, 2023 (the Record Date), 5,011,486 votes (approximately 58.6% of the total eligible votes) were represented by proxy or in person, which constituted a quorum for the purposes of the Annual Meeting.
Click here for a summary of the proposals voted on at the Annual Meeting, including the number of votes cast for, against, and the number of votes withheld and broker non-votes, with respect to each proposal.